Showing results (281-290 of 354) with videos related to

Sort By:
Pageof 36
Allergy|November 20, 2012
Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polypsP Gevaert, K T Nouri-Aria, H Wu, et al.
Allergy|May 9, 2006
Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN projectJ Bousquet, J M Anto, C Bachert, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 22, 2014
Staphylococcal enterotoxin sensitization in a community-based population: a potential role in adult-onset asthmaW-J Song, Y-S Chang, M-K Lim, et al.
Rhinology|November 28, 2012
Executive summary of European Task Force document on diagnostic tools in rhinologyP W Hellings, G Scadding, I Alobid, et al.
Rhinology|January 30, 2023
Evaluating treatment response to mepolizumab in patients with severe CRSwNPC Hopkins, J K Han, V J Lund, et al.
Allergy|November 19, 2010
Reliability of EP3OS symptom criteria and nasal endoscopy in the assessment of chronic rhinosinusitis--a GA² LEN studyP Tomassen, R B Newson, R Hoffmans, et al.
Allergy|March 18, 2017
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statementP W Hellings, W J Fokkens, C Bachert, et al.
Rhinology|July 17, 2026
Dupilumab in chronic rhinosinusitis without nasal polyps: randomized phase 2 trial (ORION)S E Lee, A T Peters, P Gevaert, et al.
Allergy|October 15, 2013
Staphylococcus aureus enterotoxin-specific IgE is associated with asthma in the general population: a GA(2)LEN studyP Tomassen, D Jarvis, R Newson, et al.
Rhinology|November 27, 2022
Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNPC Bachert, P W Hellings, V J Lund, et al.
Pageof 36